Connect with us

Press Releases

Suny Optometry’s University Eye Center Announces New Chief of Pediatrics

She will lead the implementation of new state-of-the-art center for pediatric eye care.

mm

Published

on

(PRESS RELEASE) NEW YORK — SUNY College of Optometry’s University Eye Center recently announced that Dr. Deborah Amster has officially joined as the chief of pediatric service and will head the implementation of the new Center for Pediatric Eye Care set to open in early 2020. The center will offer expanded services to children and their families.

“With her impressive clinical and teaching experiences, SUNY Optometry is proud to have Dr. Amster lead our new Center for Pediatric Eye Care,” said SUNY Optometry President Dr. David Heath. “The unparalleled services we provide to children and their families will certainly be enhanced by her leadership, as well as her deep passion for emphasizing the importance of pediatric vision services and access to care for underserved communities.”

Podcast: Is Eyecare in Canada Really More Like the US Than We Think?
INVISION Podcast

Podcast: Is Eyecare in Canada Really More Like the US Than We Think?

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?
INVISION Podcast

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries
INVISION Podcast

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries

Dr. Amster joins SUNY Optometry after 16 years of teaching and conducting research, including participation in national multi-center studies such as PDIG (Pediatric Eye Disease Group) and CITT (Convergence Insufficiency Treatment Trial), at Nova Southeastern University (NSU) ’s College of Optometry. She is both a fellow of the American Academy of Optometry and of the College of Optometrists in Vision Development. Amster completed her residency in pediatrics and binocular vision at NSU after graduating from the New England College of Optometry in 2001.

“It is a true privilege to lead the pediatrics division at SUNY Optometry, one of the most renowned patient care and academic institutions in the nation,” said Dr. Amster. “Through pediatric eye care, optometrists help to improve and enhance children’s vision so they may function and thrive academically, recreationally and socially. I look forward to working with patients and families to set them up for a lifetime of healthy vision – while also carrying on the College’s mission of delivering quality and innovative care, empowering our students, and impacting the local community as well as the field of optometry.”

The University Eye Center’s new Center for Pediatric Eye Care will be a 5,000 sq. ft. center designed from the ground up to accommodate all pediatric patients, including eight exam rooms which are fully-equipped with state-of-the-art equipment and technology, an interactive child-friendly waiting area, a separate quiet waiting room designed with soothing sensory stimulation, and an optical shop designed just for children. The new Center was funded through the Our Vision for Children Campaign which included significant donations from Barbara Saltzman, chair of the Optometric Center of New York – the college’s affiliated foundation; the Stavros Niarchos Foundation, one of the world’s leading philanthropic organizations; and other generous donors.

Before her appointment as chief of pediatric service, Dr. Amster authored chapters in optometric textbooks, co-authored peer-reviewed papers in scientific journals, and delivered many presentations and public lectures. She also chaired NSU’s Quality Assurance Committee, lectured at national meetings, and actively mentored students and residents during her NSU tenure.

Advertisement

All SUNY Optometry students will rotate through Dr. Amster’s pediatric service division during their time at the college.

Advertisement

SPONSORED VIDEO

SPONSORED BY KENMARK

Jump In — the Water’s Fine!

With a salute to summer’s shimmery, mermaid colors and warm weather-loving shades, Kenmark Eyewear celebrates this summer’s Aloha spirit with eyewear from Vera Wang, Kensie, Zac Posen and the Original Penguin Collection!

Promoted Headlines

Press Releases

First US Patient Gets Wireless Retinal Device Implant

It’s aimed at restoring partial sight to patients with advanced age-related macular degeneration.

mm

Published

on

(PRESS RELEASE) PITTSBURGH – UPMC has implanted the first patient in the U.S. with a new wireless retinal device as part of a clinical trial aimed at restoring partial sight to patients with advanced age-related macular degeneration.

“Vision research has advanced dramatically in the recent past and UPMC is at the forefront of this revolution. This is the first of many such breakthroughs led by UPMC and Pitt that will benefit patients with vision loss in our community and around the world,” said José-Alain Sahel, MD, director of the UPMC Eye Center, Eye and Ear Foundation chair of ophthalmology and distinguished professor at the University of Pittsburgh School of Medicine who initiated the trial at UPMC. “We are proud to be the first center in the United States to test this next generation retinal implant that could help treat an incurable disease like AMD.”

Podcast: Is Eyecare in Canada Really More Like the US Than We Think?
INVISION Podcast

Podcast: Is Eyecare in Canada Really More Like the US Than We Think?

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?
INVISION Podcast

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries
INVISION Podcast

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries

The system, called PRIMA, is designed to restore sight in patients blinded by retinal degeneration. It consists of a 2 millimeter-by-2 millimeter, 30-micron thick miniaturized wireless photovoltaic chip placed under the damaged retina. It works in tandem with augmented reality glasses that have a built-in miniaturized camera and infrared projector.

The chip acts like a tiny artificial retina, made up of 378 tiny electrodes that convert infrared light from the glasses to electrical signals that are carried by the optic nerve to the brain. After receiving the implant, patients undergo an intensive rehabilitation program that trains their brains to understand and interpret the signals from the implant in combination with their remaining natural vision. Compared to earlier-generation implants, PRIMA is wireless and has significantly more electrodes, which allows for the transmission of more visual information.

“This is an incredibly exciting first for us at UPMC and I’m honored to be a part of it,” said Joseph Martel, MD, the implanting surgeon at the UPMC Eye Center and the Pitt School of Medicine, and the principal investigator of the trial at UPMC. “I’m grateful to our patients who have volunteered to participate in this trial, without whom this would not be possible.”

AMD is the leading cause of vision loss in people older than 50. Today, it affects approximately 14 million people in the United States, and the prevalence is expected to rise as the baby boomers age. As AMD progresses, the center of vision becomes increasingly blurry. “Atrophic” AMD, which accounts for a large proportion of advanced cases, has no curative treatment available.

The UPMC feasibility trial is running in parallel with the first-in-human trial in France, which involves five patients with advanced AMD, who now have been followed for more than a year. The 12-month results from the French study demonstrated the ability of most patients to identify sequences of letters and there were no device-related serious adverse effects.

“We are working with a great sense of urgency because the aging population of the United States, especially the western Pennsylvania region we live in, will see a significant rise in the number of patients at risk for vision loss through diseases like age-related macular degeneration, glaucoma and vascular eye disease, as well as earlier onset genetic conditions such as retinitis pigmentosa,” said Sahel. “This is why our physicians and researchers at UPMC and Pitt, in collaboration with our U.S. and international colleagues — especially at the Paris Vision Institute at Sorbonne University — are taking a multi-pronged effort to treat and rehabilitate patients with vision impairments.”

In March 2019, UPMC broke ground on the UPMC Vision and Rehabilitation Tower at UPMC Mercy, which when completed, will provide advanced specialty clinical care and innovative programs for visually impaired patients. It also will be the home for the vision research program at Pitt and UPMC.

The PRIMA implant was invented by Daniel Palanker, professor of ophthalmology at Stanford University, and licensed and developed by Pixium Vision, a spin-off from the Paris Vision Institute. Sahel is a co-founder of Pixium and holds shares in the company.

Continue Reading

Press Releases

There Might Be a Faster and Cheaper Way to Test for Myopia

The research comes from Flinders University in Australia.

mm

Published

on

(PRESS RELEASE) Myopia could become significantly easier to assess, according to a group of scientists.

Progressive research at Flinders University in Australia has identified a new method to measure how it affects the eye, a new article in PLOS ONE reveals.

Podcast: Is Eyecare in Canada Really More Like the US Than We Think?
INVISION Podcast

Podcast: Is Eyecare in Canada Really More Like the US Than We Think?

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?
INVISION Podcast

Podcast: What Exactly Does it Take to Become America’s Finest Optical Retailer?

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries
INVISION Podcast

Podcast: Why Optical (and Especially Optical Retail) Is Lagging Behind Other Industries

The work was based on testing of 70 volunteers, with the Flinders ophthalmology and medical device research institute experts taking a novel approach with optical coherence tomography (OCT), a device already available in most optometric and all ophthalmic practices.

“Our work uses the OCT and finds irregularities at this scale that correlate with the size of the eye, and therefore the degree of myopia,” says eye specialist Dr. Stewart Lake, from Flinders University.

“This may help monitor, measure, and explore the effects of myopia and how it leads to vision loss,” he says, adding that further development could make the system suitable for use in regular clinical practice.

Prior research elsewhere with MRI scanning has demonstrated large scale irregularities in the eyeball in highly myopic eyes.

OCT can sample the shape of the eye on a much smaller scale than MRI. The OCT testing will be far cheaper, is more readily available and repeatable as a test, researchers say in the article.

Myopia (short or near-sightedness) is for many an inconvenience requiring glasses or contact lens to correct. However, globally it is an epidemic and a major cause of vision loss and sometimes blindness.

Myopia is defined practically by the strength of lens required to correct eyesight. It was already known that myopia relates strongly to the size/length of the eyeball.

Global estimates forecast up to 5 billion people will have myopia and 1 billion people could suffer with high myopia by 2050, placing a significant burden on health systems to manage and prevent myopia-related ocular complications and vision loss.

This seven-fold increase, between 2000 and 2050, would make myopia the leading cause of permanent blindness worldwide.

High myopia increases the risk of pathological ocular changes such as cataract, glaucoma, retinal detachment and myopic macular degeneration, all of which cause irreversible vision loss

Continue Reading

Press Releases

Prevent Blindness Promotes Glaucoma Awareness This Month

More than 3.2 million Americans ages 40 and over have the condition.

mm

Published

on

(PRESS RELEASE) CHICAGO – According to estimates from the Prevent Blindness report “Future of Vision: Forecasting the Prevalence and Costs of Vision Problems,” more than 3.2 million Americans ages 40 and over have glaucoma in the year 2020. The number is expected to increase as the population ages. Glaucoma, often referred to as the “the sneak thief of sight,” is a leading cause of vision loss that damages the optic nerve. Although symptoms may not be noticeable at first, glaucoma slowly diminishes peripheral vision, making activities such as driving increasingly difficult.

January is National Glaucoma Awareness Month and Prevent Blindness, the nation’s oldest volunteer eye health and safety nonprofit organization, seeks to educate the public on the disease, including risk factors, types of glaucoma, treatment options and more. Prevent Blindness offers a dedicated web page providing patients and their caregivers with free information at https://www.preventblindness.org/glaucoma or its online resource, Living Well with Low Vision at https://lowvision.preventblindness.org.

More women than men have glaucoma. Risk factors for glaucoma also include:

  • Age – The older you are, the greater you are at risk (especially those more than 60 years old).
  • Race – African-Americans age 40 and over are 4-5 times more likely to have glaucoma than others. Hispanics are also at increased risk for glaucoma as they age. Those of Asian and Native American descent are at increased risk for angle closure glaucoma.
  • Family History – If you have a direct relative with glaucoma, you are more likely to get glaucoma. If you are diagnosed with glaucoma, strongly encourage your family members to get complete eye exams.
  • Medical History – You are at higher risk if you have a history of high pressure in the eyes, previous eye injury, long term steroid use, or are farsighted or nearsighted.

The American Academy of Ophthalmology (AAO) also states that those with diabetes, migraines, high blood pressure, poor blood circulation or other health problems affecting the whole body are at increased risk of glaucoma.

“The year 2020 is an ideal reminder for all of us to make the resolution today to save our vision for tomorrow,” said Jeff Todd, president and CEO of Prevent Blindness. “By detecting vision problems and treating them early, including those from glaucoma, we can help to avoid significant vision impairment.”

Continue Reading

Advertisement

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Facebook

Most Popular